Associated Papers
Case report: Novel compound heterozygous IL1RN mutations as the likely cause of a lethal form of deficiency of interleukin-1 receptor antagonist.
Urbaneja E et al.
Frontiers in Immunology, 2024
Autoinflammatory Keratinization Diseases-The Concept, Pathophysiology, and Clinical Implications.
Blicharz L et al.
Clinical Reviews in Allergy & Immunology, 2023
A case report of a novel compound heterozygous mutation in a Brazilian patient with deficiency of Interleukin-1 receptor antagonist (DIRA).
Mendonça LO et al.
Pediatric Rheumatology Online Journal, 2020
Monogenic Autoinflammatory Diseases with Mendelian Inheritance: Genes, Mutations, and Genotype/Phenotype Correlations.
Martorana D et al.
Frontiers in Immunology, 2017
Working the endless puzzle of hereditary autoinflammatory disorders.
Caso F et al.
Modern Rheumatology, 2014
Autoinflammatory bone disorders: update on immunologic abnormalities and clues about possible triggers.
Sharma M et al.
Current Opinion in Rheumatology, 2013
Current understanding of the pathogenesis and management of chronic recurrent multifocal osteomyelitis.
Ferguson PJ et al.
Current Rheumatology Reports, 2012
An autoinflammatory disease with deficiency of the interleukin-1-receptor antagonist.
Aksentijevich I et al.
The New England Journal of Medicine, 2009
Select a paper to view details